First-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy pain.

Walicke, Patricia A; Hefti, Franz; Bales, Roxanne; Lu, Shiao-Ping; Ruckle, Jon L; Brown, Mark T; West, Christine R; Shelton, David L

Walicke, Patricia A; Hefti, Franz; Bales, Roxanne; Lu, Shiao-Ping; Ruckle, Jon L; Brown, Mark T; West, Christine R; Shelton, David L.

Afiliação

Walicke PA; Rinat Neuroscience (a subsidiary of Pfizer Inc), South San Francisco, CA, USA.
Hefti F; Rinat Neuroscience (a subsidiary of Pfizer Inc), South San Francisco, CA, USA.
Bales R; Rinat Neuroscience (a subsidiary of Pfizer Inc), South San Francisco, CA, USA.
Lu SP; Rinat Neuroscience (a subsidiary of Pfizer Inc), South San Francisco, CA, USA.
Ruckle JL; Radiant Research, Honolulu, HI, USA.
Brown MT; Pfizer Inc, Clinical Development and Operations Business Unit, Groton, CT, USA.
West CR; Pfizer Inc, Clinical Development and Operations Business Unit, Groton, CT, USA.
Shelton DL; Rinat Neuroscience (a subsidiary of Pfizer Inc), South San Francisco, CA, USA.

Pain Rep ; 3(3): e653, 2018 May.

Article em En | MEDLINE | ID: mdl-29922745

Palavras-chave

Analgesia; Bunionectomy; Nerve growth factor; Osteoarthritis; Safety; Tanezumab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Pain Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google